Ryerson Holding Corp (RYI) CFO discloses additional RSU dividend credits

Rhea-AI Filing Summary

Ryerson Holding Corp's Executive Vice President and CFO reported additional equity-based awards tied to prior grants. On December 18, 2025, the officer acquired dividend equivalent rights in the form of restricted stock units that correspond to 30.065, 58.801, and 97.285 shares of common stock, each at a price of $0. These units arise when cash dividends are paid on previously granted restricted stock units and are intended to mirror those dividends in stock form.

The dividend equivalent rights relate to restricted stock units originally granted on March 31, 2023, March 31, 2024, and March 31, 2025. The underlying unvested restricted stock units and their associated dividend equivalent rights are scheduled to vest on March 31, 2026, and, for later awards, also on March 31, 2027 and March 31, 2028. Following these transactions, the officer reports beneficial ownership of derivative securities labeled as restricted stock units in amounts including 4,179.702, 8,174.775, and 13,525.18 units, all held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Claussen James J

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/18/2025		A		30.065(2)		(3)	(3)	Common Stock	30.065	$0	4,179.702	D
Restricted Stock Units	(1)	12/18/2025		A		58.801(2)		(4)	(4)	Common Stock	58.801	$0	8,174.775	D
Restricted Stock Units	(1)	12/18/2025		A		97.285(2)		(5)	(5)	Common Stock	97.285	$0	13,525.18	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

	/s/ Camilla Rykke Merrick, attorney-in-fact	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ryerson Holding Corp (RYI) report in this Form 4?

The filing reports that the Executive Vice President & CFO acquired additional restricted stock units in the form of dividend equivalent rights tied to existing equity awards on December 18, 2025.

How many dividend equivalent restricted stock units did the RYI CFO receive?

The officer received dividend equivalent restricted stock units corresponding to 30.065, 58.801, and 97.285 shares of Ryerson Holding Corp common stock.

Did the Ryerson Holding Corp CFO pay anything for these new restricted stock units?

No cash was paid for these awards; the filing lists the price as $0 for each block of dividend equivalent restricted stock units.

What are dividend equivalent rights in the context of Ryerson Holding Corp (RYI) RSUs?

The filing explains that dividend equivalent rights accrue when and as dividends are paid on the common shares underlying restricted stock units and vest proportionately and are settled on the same terms as the related restricted stock units.

When will these Ryerson Holding Corp dividend equivalent RSUs vest?

The dividend equivalent rights tied to RSUs granted on March 31, 2023 vest on March 31, 2026. Those tied to March 31, 2024 grants vest on March 31, 2026 and March 31, 2027, and those tied to March 31, 2025 grants vest on March 31, 2026, March 31, 2027, and March 31, 2028.

How many restricted stock units does the Ryerson Holding Corp CFO report owning after this transaction?

After these transactions, the officer reports beneficial ownership of restricted stock units in amounts including 4,179.702, 8,174.775, and 13,525.18 derivative securities, all held directly.

Who signed the Ryerson Holding Corp (RYI) Form 4 for this transaction?

The Form 4 was signed by Camilla Rykke Merrick as attorney-in-fact for the reporting person on December 22, 2025.